Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 3Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3

Conditions

Thyroid Neoplasms 1Thyroid Diseases 1Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

Specimen Handling 76Cisplatin 64Drug Therapy 63Carboplatin 63Bevacizumab 63Magnetic Resonance Spectroscopy 59Radiotherapy 57Gemcitabine 54Cyclophosphamide 54pembrolizumab 52Oxaliplatin 49Capecitabine 49toripalimab 44Paclitaxel 40tislelizumab 39Standard of Care 39fludarabine 36Injections 34Fluorouracil 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 28Nivolumab 28Surgical Procedures, Operative 27Irinotecan 27Docetaxel 27Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroxine × 1 year × Clear all
NCT06647602 2026-02-10

THRIVE

University Medical Center Groningen

Not yet recruiting
40 enrolled
Head & Neck

Thyroid Neoplasms

NCT06790589 2026-02-06

COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

AHS Cancer Control Alberta

Phase 2 Not yet recruiting
70 enrolled
Head & Neck

Advanced Differentiated Thyroid Gland Carcinoma

NCT07239674 2025-11-20

DELTA

West China Hospital

Phase 3 Not yet recruiting
646 enrolled
Head & Neck

Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡